BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35664272)

  • 1. An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
    Li M; Xu G
    Clin Kidney J; 2022 Jun; 15(6):1041-1048. PubMed ID: 35664272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review on the Diagnosis and Treatment of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits.
    Lin L; Chen N
    Int J Gen Med; 2022; 15():8577-8582. PubMed ID: 36540764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective.
    Bridoux F; Javaugue V; Nasr SH; Leung N
    Nephrol Dial Transplant; 2021 Jan; 36(2):208-215. PubMed ID: 33494099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clone-directed therapy for proliferative glomerulonephritis with monoclonal immunoglobulin depositions: is it always necessary? : Two case reports and literature review.
    van Kruijsdijk RCM; Abrahams AC; Nguyen TQ; Minnema MC; Jacobs JFM; Limper M
    J Nephrol; 2020 Jun; 33(3):611-617. PubMed ID: 32221859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone.
    Nasr SH; Larsen CP; Sirac C; Theis JD; Domenger C; Chauvet S; Javaugue V; Hogan JJ; Said SM; Dasari S; Vrana JA; McPhail ED; Cornell LD; Vilaine E; Massy ZA; Boffa JJ; Buob D; Toussaint S; Guincestre T; Touchard G; D'Agati VD; Leung N; Bridoux F
    Kidney Int; 2020 Mar; 97(3):589-601. PubMed ID: 32001067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
    Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
    BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) that responded favorably to steroid therapy.
    Ogura Y; Yabushita S; Aihara H; Tsukada H; Hashiba T; Furuse S; Fujii A; Ueda Y; Mise N
    CEN Case Rep; 2022 May; 11(2):208-215. PubMed ID: 34628583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGNMID and anti-CD38 monoclonal antibody: a therapeutic challenge.
    Rahbari E; Barreca A; Nicolino B; Ciochetto C; Piraina V; Maroni S; Deagostini MC; Patti R; Bertucci P; Savoldi S
    G Ital Nefrol; 2022 Feb; 39(1):. PubMed ID: 35191627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits triggered by COVID-19: a case report.
    Shieh M; Giannini JA; Combs SA; Shaffi SK; Messias NC; Teixeira JP
    CEN Case Rep; 2022 Aug; 11(3):380-385. PubMed ID: 35122206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative glomerulonephritis associated with monoclonal immune deposits: A case report and review of literature.
    Fatima R; Jha R; Gowrishankar S; Narayen G; Rao BS
    Indian J Nephrol; 2014 Nov; 24(6):376-9. PubMed ID: 25484532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an entity associated with distinct diseases and comparison between IgG1 and IgG3 subtypes.
    Liu M; Yu X; Wang S; Qin A; Zhou F; Zhao M
    J Nephrol; 2022 Dec; 35(9):2363-2372. PubMed ID: 35460458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative Glomerulonephritis With Monotypic Immunoglobulin Deposits: An Unusual Presentation in the Setting of Multiple Inciting Events Including COVID-19 Vaccination.
    Vanjarapu JMR; Iglesias J; Ahmed R; Singh P; Gerbino G; Stokes MB
    Cureus; 2022 Jun; 14(6):e25949. PubMed ID: 35855226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
    Sato K; Makabe S; Iwabuchi Y; Kojima K; Sato M; Kataoka H; Moriyama T; Taneda S; Tsuchiya K; Nitta K; Mochizuki T
    Nephrology (Carlton); 2018 Aug; 23(8):787-790. PubMed ID: 29577510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tale of monoclonal immunoglobulin: Clinicopathological analysis of proliferative glomerulonephritis with monoclonal immunoglobulin deposit.
    Maity P; Dasgupta S; Basu K; Sengupta M; Chowdhury AR; Bandopadhyay M
    Indian J Pathol Microbiol; 2021; 64(2):282-287. PubMed ID: 33851621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits.
    Vignon M; Cohen C; Faguer S; Noel LH; Guilbeau C; Rabant M; Higgins S; Hummel A; Hertig A; Francois H; Lequintrec M; Vilaine E; Knebelmann B; Pourrat J; Chauveau D; Goujon JM; Javaugue V; Touchard G; El Karoui K; Bridoux F
    Kidney Int; 2017 Mar; 91(3):720-728. PubMed ID: 28069266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membranoproliferative glomerulonephritis with deposition of monoclonal IgG evolved from polyclonal IgG: a case report with two consecutive renal biopsies.
    Yu XJ; Hu N; Wang SX; Zhou FD; Zhao MH
    BMC Nephrol; 2019 Jul; 20(1):275. PubMed ID: 31331283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgM kappa proliferative glomerulonephritis with monoclonal immunoglobulin deposition complicated with nocardiosis dermatitis: a case report and review of literature.
    Chen K; Wang Y; Yu J; Wang X; Xu Z; Li Y; Sun W
    Front Med (Lausanne); 2024; 11():1161560. PubMed ID: 38681054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance.
    Lee H; Duggan P; Neri P; Tay J; Jimenez-Zepeda VH
    Mediterr J Hematol Infect Dis; 2019; 11(1):e2019007. PubMed ID: 30671213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation and cryoglobulinemia are common in monoclonal gammopathy of renal significance: Data from a case series.
    Škoberne A; Škerget M; Kojc N; Frelih M; Rigler AA; Haler ŽV; Borštnar Š; Rotar NA; Kovač D; Lindič J; Zver S
    Clin Nephrol; 2021 Suppl; 96(1):16-23. PubMed ID: 34643486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide for the Treatment of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposition.
    Asif S; Mahmood SN; Mukhtar KN
    Saudi J Kidney Dis Transpl; 2021; 32(4):1166-1170. PubMed ID: 35229819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.